Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Management of Migraine Using Enerumab and Traditional Therapy at the Time of COVID-19

NCT05052008 is registered in ClinicalTrials.gov with Fayoum University as lead sponsor.

NCT NCT05052008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05052008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Management of Migraine Using Enerumab and Traditional Therapy at the Time of COVID-19
Lead sponsor
Fayoum University
Phase
Observational
Overall status
Completed
Start date
August 15, 2020
Completion date
September 10, 2021
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine disorders